Concentra Biosciences, Llc Jounce Therapeutics, Inc. (JNCE) insider trading activity

JNCE Quotes by TradingView

Concentra Biosciences, LLC is > 10% Shareholder of Jounce Therapeutics, Inc.. Currently has a direct ownership of 10,000 shares of JNCE, which is worth approximately $0. The most recent transaction as insider was on May 03, 2023, when has been sold 10,000 shares (Common Stock) at a price of $9737.7 per share, resulting in proceeds of $97,377,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $0

Concentra Biosciences, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 03 2023
BUY
Other acquisition or disposition
$97,377,000 $9737.7 p/Share
10,000 Added 50.0%
10,000 Common Stock
CBL

Concentra Biosciences, LLC

> 10% Shareholder
San Diego, CA

Track Institutional and Insider Activities on JNCE

Follow Jounce Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

News

Receive news related to Jounce Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNCE